Bernal José M, Naranjo Sara, Trugeda Manuel, Sarralde Aurelio, Diago Carmen, Revuelta José M
Cirugía Cardiovascular, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Av. Marqués de Valdecilla s/n, 39008 Santander, Spain.
Rev Esp Cardiol. 2006 May;59(5):507-9.
As patients who are Jehovah's Witnesses are against blood transfusion, they are difficult to manage when a cardiac intervention is required. Between 1998 and 2004, all Jehovah's Witness patients with an indication for cardiac surgery (n=10) were operated on by the same multidisciplinary team. The mean fall in hematocrit was 30% during cardiopulmonary bypass, 35% during the postoperative period, and 22% at discharge. One patient required cardiac re-exploration because of sternal bleeding. All patients survived operation and were discharged. At follow-up, 1 patient died due to respiratory failure. Technological developments that reduce bleeding and enable lost blood to be recovered have made it possible to perform operations involving a risk of hemorrhage in Jehovah's Witnesses.
由于耶和华见证人的患者反对输血，在需要进行心脏介入治疗时很难处理。1998年至2004年间，所有有心脏手术指征的耶和华见证会患者（n = 10）均由同一多学科团队进行手术。体外循环期间血细胞比容平均下降30%，术后下降35%，出院时下降22%。1例患者因胸骨出血需要再次开胸探查。所有患者均手术存活并出院。随访时，1例患者因呼吸衰竭死亡。减少出血并能回收失血的技术发展使得对有出血风险的耶和华见证会患者进行手术成为可能。
